Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06795152 · ClinicalTrials.gov registry record
Rare Glycogen Storage Diseases Natural History Study
A clinical trial of Glycogen Storage Disease and GSD Type 0A, sponsored by Duke University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06795152: Recruiting study of Glycogen Storage Disease and GSD Type 0A, sponsored by Duke University.
NCT06795152 is a study of Glycogen Storage Disease and GSD Type 0A that is actively recruiting participants, run by Duke University. The registered enrollment target is 200 participants, above the 44-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (355% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06795152, a study of Glycogen Storage Disease and GSD Type 0A, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-12-23 |
| Est. Completion | 2034-12 |
What NCT06795152 shows while recruiting
NCT06795152 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, above the 44-participant average among 3 other Glycogen Storage Disease trials with a reported enrollment target (355% higher).
The record links to 10 conditions, with Glycogen Storage Disease appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT06795152 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT06795152 about?
NCT06795152 is a clinical study titled "Rare Glycogen Storage Diseases Natural History Study". The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
What is the current status of trial NCT06795152?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-12-23. Estimated completion is 2034-12.
What conditions does trial NCT06795152 study?
This clinical trial studies the following conditions: Glycogen Storage Disease, GSD Type 0A, GSD Type 0B, GSD VII, Tarui Disease.
What interventions are being tested in trial NCT06795152?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT06795152?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06795152 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Glycogen Storage Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI